These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 4580808)

  • 1. Experimental approaches to endometrial and ovarian cancer.
    Brush MG
    Postgrad Med J; 1973 Feb; 49(568):73-6. PubMed ID: 4580808
    [No Abstract]   [Full Text] [Related]  

  • 2. [Progestational hormones and cancer of the endometrium].
    Lambotte R; Hustin J
    Rev Med Liege; 1973 Oct; 28(19):662-7. PubMed ID: 4767877
    [No Abstract]   [Full Text] [Related]  

  • 3. Current status of the management of patients with endocrine-sensitive tumors. II. Carcinoma of the prostate, endometrium, thyroid, kidney and miscellaneous tumors.
    Crowley LG; Duwe SA
    Calif Med; 1969 Feb; 110(2):139-50. PubMed ID: 4894628
    [No Abstract]   [Full Text] [Related]  

  • 4. [Progestational hormones in the treatment of gynecologic cancers].
    Soutoul JH; Lagabrielle V
    Presse Med (1893); 1969 Feb; 77(7):247-9. PubMed ID: 5795418
    [No Abstract]   [Full Text] [Related]  

  • 5. [Use of chemotherapy in oncogynecology].
    Nechaeva ID; Kotova DG
    Vopr Onkol; 1978; 24(3):106-15. PubMed ID: 347710
    [No Abstract]   [Full Text] [Related]  

  • 6. [Progestational hormones in endometrial carcinoma].
    Corres Innes J; Zazueta Valadez F; Vela Lugo C
    Ginecol Obstet Mex; 1967 Sep; 22(131):1193-203. PubMed ID: 5602498
    [No Abstract]   [Full Text] [Related]  

  • 7. Palliation of metastatic endometrial adenocarcinoma with dimethisterone.
    Morrison J; Blunt VA
    Aust N Z J Obstet Gynaecol; 1972 Feb; 12(1):27-9. PubMed ID: 4112032
    [No Abstract]   [Full Text] [Related]  

  • 8. Use of progestational agents in the management of endometrial cancer.
    Kistner RW; Griffiths CT; Craig JM
    Cancer; 1965 Dec; 18(12):1563-79. PubMed ID: 5891823
    [No Abstract]   [Full Text] [Related]  

  • 9. [Duration and generation time of DNA replication in ovarian and endometrial carcinomas. Autoradiographic studies].
    Brachetti AK; Haas P; Schuster T
    Med Welt; 1975 Jun; 26(24):1184-7. PubMed ID: 1160590
    [No Abstract]   [Full Text] [Related]  

  • 10. [Use of progestational hormones in the treatment of advanced stages of breast and gynaecologic carcinoma].
    Guérin MT; Guérin RA
    Sem Hop; 1969 Dec; 45(51):3241-3. PubMed ID: 4312573
    [No Abstract]   [Full Text] [Related]  

  • 11. Adjuvant chemotherapy for cancer of the corpus uteri. Preliminary report.
    Lewis GC; Nadler SH; Bross ID; Slack NH
    Obstet Gynecol; 1967 Jun; 29(6):797-802. PubMed ID: 5338150
    [No Abstract]   [Full Text] [Related]  

  • 12. Combination of progestogen therapy with the conventional treatment of endometrial carcinoma.
    Luukkainen T; Karjalainen O
    Bull Schweiz Akad Med Wiss; 1970 Oct; 25(4-6):581-5. PubMed ID: 5510182
    [No Abstract]   [Full Text] [Related]  

  • 13. The value of progestational agents against carcinoma of the endometrium.
    Rauramo L
    Ann Chir Gynaecol Fenn; 1970; 59(2):59-60. PubMed ID: 5454249
    [No Abstract]   [Full Text] [Related]  

  • 14. The use of oestradiol uptake and binding-site studies in endometrial and ovarian carcinoma.
    Taylor RW; Brush MG; King RJ
    Postgrad Med J; 1973 Feb; 49(568):77. PubMed ID: 4729186
    [No Abstract]   [Full Text] [Related]  

  • 15. [Effect of progestagens on neoplastic tissue and endometrium in patients with diagnosed uterine corpus cancer].
    Swiatkowska H; Sikorowa L; Teter J; Tarlowska L; Zieliński J
    Ginekol Pol; 1975 Jul; 46(7):761-8. PubMed ID: 168129
    [No Abstract]   [Full Text] [Related]  

  • 16. The use of progestational agents in the management of hyperplasia, carcinoma in situ, and disseminated cancer of the endometrium.
    Kistner RW
    J Am Osteopath Assoc; 1971 Aug; 70(12):1324. PubMed ID: 5209200
    [No Abstract]   [Full Text] [Related]  

  • 17. The use of progestational agents in the treatment of carcinoma of the endometrium.
    McDuff HC; Barrall JH
    Trans N Engl Obstet Gynecol Soc; 1965; 19():75-89. PubMed ID: 5872595
    [No Abstract]   [Full Text] [Related]  

  • 18. A randomized trial of progestogens in the primary treatment of endometrial carcinoma.
    Kneale BL; Quinn MA; Rennie GC
    Br J Obstet Gynaecol; 1988 Aug; 95(8):828. PubMed ID: 3048376
    [No Abstract]   [Full Text] [Related]  

  • 19. [Effect of gestagen on uterine adenocarcinoma of the endometrium in the human, with special reference to electron microscope study].
    Hayakawa K; Okudaira Y; Nasu K; Iijima H; Taki I
    Nihon Sanka Fujinka Gakkai Zasshi; 1968 Nov; 20(11):1528-9. PubMed ID: 5752842
    [No Abstract]   [Full Text] [Related]  

  • 20. The application of dose intensity to problems in chemotherapy of ovarian and endometrial cancer.
    Levin L; Hryniuk W
    Semin Oncol; 1987 Dec; 14(4 Suppl 4):12-9. PubMed ID: 3120317
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.